-
Congress is wrapping up the year without a lot of legislative accomplishments under its belt and a growing list of lawmakers who are retiring. Former members say the challenges on Capitol Hill have been brewing for a long time.
-
With months-long consulate and embassy delays being reported, the two tech companies say staying put in the U.S. right now could prevent workers from getting stranded in their home countries.
-
The Department of Justice began releasing its files on Friday on the late pedophile Jeffrey Epstein. Many documents, which include interview transcripts and call logs, have been heavily redacted.
-
MAGA activists meet in Phoenix, President Trump addresses the nation and his fans, and Democrats grapple with how they lost in 2024.
-
President Trump won re-election in 2024 on a promise to upend Washington. He pitched a presidency where he alone could solve America's problems. Where does the current reality of these promises stand?
-
MAGA infighting was underway as Turning Point USA opened its first national conference since the death of Charlie Kirk.
-
The Justice Department released some of the Epstein files, including many previously public documents, related to convicted sex offender Jeffrey Epstein's criminal charges and his death by suicide in federal custody.
-
A federal judge said HUD cannot dramatically change its funding policies on homelessness for now. States, cities and nonprofits say the proposed overhaul would push thousands back onto the streets.
-
The White House plans to break up a key weather and climate research center in Colorado, a move experts say could jeopardize the accuracy of forecasting and prediction systems.
-
A local compounding pharmacy is planning to transform the former courthouse into a mixed-use facility containing office space, retail and a pharmacy.
-
Is President Trump's economic message is connecting in battleground states such as North Carolina.
-
President Trump signed an executive order on Thursday requiring his administration to downgrade marijuana from a Schedule I to Schedule III drug.